Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir for CMV Viraemia in Advanced HIV Disease
NCT07379203Phase 2Not yet recruiting
- Sponsor
- Wits Health Consortium
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by Wits Health Consortium. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT07379203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07379203.